Answer
Jun 05, 2025 - 01:53 PM
Nintedanib is a medication primarily used to treat idiopathic pulmonary fibrosis (IPF) and certain types of non-small cell lung cancer, as well as systemic sclerosis-associated interstitial lung disease. While it can slow disease progression and improve quality of life, it does not cure these conditions. The life expectancy of someone taking nintedanib varies significantly based on the individual's overall health, disease severity, and response to treatment. It is best discussed with a healthcare provider familiar with the patient's specific medical situation.
